Drug Shortage Report for ACTEMRA

Last updated on 2022-12-07 History
Report ID 157625
Drug Identification Number 02424770
Brand name ACTEMRA
Common or Proper name ACTEMRA
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) TOCILIZUMAB
Strength(s) 162MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size Pre-filled Syringe
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-05-15
Actual start date 2022-05-09
Estimated end date
Actual end date 2022-12-06
Shortage status Resolved
Updated date 2022-12-07
Company comments Due to ongoing global product constraint, orders containing this product will be fulfilled based on current supply.
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-03-31 English Compare
v2 2022-03-31 French Compare
v3 2022-04-12 English Compare
v4 2022-04-12 French Compare
v5 2022-05-01 English Compare
v6 2022-05-03 English Compare
v7 2022-05-03 French Compare
v8 2022-05-09 English Compare
v9 2022-05-09 French Compare
v10 2022-05-10 English Compare
v11 2022-07-21 English Compare
v12 2022-07-21 French Compare
v13 2022-12-07 English Compare
v14 2022-12-07 English Compare
v15 2022-12-07 French Compare

Showing 1 to 15 of 15